Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Motor Activity × Gynecologic × Clear all

Phase

Phase NA 23 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 8 Thoracic 3 Genitourinary 3 Gastrointestinal 3 Lymphoid 2 Gynecologic 1 CNS 1

Conditions

Ovarian Neoplasms 185 Uterine Cervical Neoplasms 146 Fallopian Tube Neoplasms 78 Carcinoma, Ovarian Epithelial 67 Endometrial Neoplasms 63 Neoplasms 34 Papillomavirus Infections 26 Uterine Cervical Dysplasia 25 Breast Neoplasms 22 Vulvar Neoplasms 20 Peritoneal Neoplasms 20 Condylomata Acuminata 19 Vaginal Neoplasms 16 Recurrence 14 Testicular Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Burkitt Lymphoma 10 Brenner Tumor 10 Sarcoma 9 Primary Myelofibrosis 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Multiple Myeloma 9 Lymphoma, Non-Hodgkin 9 Lymphoma, Mantle-Cell 9 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, Follicular 9 Lymphoma, B-Cell, Marginal Zone 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Myeloid, Accelerated Phase 9

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02107066 2018-04-20

WALC

Yale University

Phase 3 Completed

Body Weight, Fatigue, Motor Activity, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡